drugset / Trial / NCT05724550

Diaphragm Function After Reversal of Rocuronium-induced Neuromuscular Blockade With Sugammadex or Neostigmine in Children

NCT05724550

Completed 73 enrolled Seoul National University Hospital
RandomizedParallel-groupQuadruple-blindPrevention

Summary

This study is to evaluate the recovery of diaphragm function and atelectasis after reversal of neuromuscular blockade with Neostigmine and Sugammadex using lung ultrasound and diaphragm ultrasound for children aged 2 to 7 who are scheduled for the surgical procedure under general anesthesia.

Timeline

Start
2023-02-22
Primary completion
2024-06-07
Completion
2024-06-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Neostigmine Other / unclassified 0.02 mg/kg
Subject Sugammadex Other / unclassified 2 mg/kg